预防子痫前期复发早期临床干预措施

doi:10.7504/fk2014090107

摘要/Abstract

摘要：

子痫前期病史是子痫前期发病的独立危险因素，复发子痫前期较初发子痫前期有严重的临床结局。但疾病复发受多因素影响，预防尤为关键。全面母体风险评估，强化孕期个体化管理，早期识别高危因素，实施早期对应性干预，是减少或避免复发的关键。

Abstract:

Abstract: A history of pre-eclampsia is an independent risk factor for recurrence of preeclampsia. Recurrence of preeclampsia has more severe clinical outcomes. Recurrence of the disease is affected by multiple factors, but prevention is the key. Comprehensive maternal risk assessment, strengthening individualized prenatal care, early identification of risk factors,and implementation of early corresponding intervention are the key to reducing or avoiding in the recurrence of preeclampsia.

Key words: preeclampsia, recurrence, risk assessment, early intervention

中图分类号:

R714.24+4

杨孜，李维. 预防子痫前期复发早期临床干预措施[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2014090107.

YANG Zi, LI Wei.. Early clinical interventions for prevention of recurrence of preeclampsia.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2014090107.

参考文献

[1］ Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies［J］. BMJ,2005,330(7491):565-572.

[2］ Milne F, Redman C, Walker J, et al. The preeclampsia community guideline （PRECOG）：how to screen for and detect onset of preeclampsia in the community［J］. BMJ, 2005,330(7491):576-580.

[3］杨孜，王伽略，黄萍,等.重度子痫前期临床发病类型及特点与围产结局的关系［J］. 中华妇产科杂志, 2006,41(5) ：302-306.

[4］杨孜，王伽略，黄萍.重度子痫前期终末器官受累不平行性及围产结局探讨［J］.中华围产医学杂志，2006,9:10-14.

[5］史俊梅，杨孜，陈蕾. 重度子痫前期患者水肿临床类型分析［J］.中华医学杂志，2014，94（17）：1342-1345.

[6］杨孜. 生物学标记结合临床风险推动子痫前期预测更上一层楼［J］. 中华围产医学杂志,2011,14(7):385-389.

[7］中华医学会妇产科学分会产科学组. 孕前和孕期保健指南(第1版)［J］. 中华妇产科杂志,2011,46(2):150-153.

[8］ National Collaborating Centre for Women's and Children's Health (UK)．Hypertension in pregnancy:the management of hypertensive disorders during pregnancy［M］.London: RCOG Press,2010.

[9］杨孜. 子痫前期预测预防是固步自封,还是探索求进强化预警［J］. 中国实用妇科与产科杂志,2014,30(1):3-7.

[10］史峻梅，杨孜，陈蕾，等. 重度子痫前期患者临床发病前预警信息分析［J］. 中华妇产科杂志, 2009,44(5):337-340.

[11］宋颖, 杨孜, 沈洁, 等. 规律产前检查轻重度子痫前期患者早期临床发病特点分析［J］. 中国实用妇科与产科杂志, 2014, 30(6): 457-461.

[12］杨孜. 早发型子痫前期临床与基础研究并进相得益彰［J］. 中国妇产科临床杂志,2010,11(4):241-243.

[13］ Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance［J］. BMJ,2010,341:c2207.

[14］ Magee LA，Helewa M，Moutquin JM，et a1．Diagnosis，evaluation，and management of the hypertensive disorders of pregnancy［J］．J Obstet Gynaecol Can，2008，30：S1-48．

[15］ American Congress of Obstetric and Gynecologists. Hypertetion in pregnancy ［J］. Obstet Gynecol, 2013,122,1122-1131.

[16］ Conde-Agudelo A, Romero R, Kusanovic JP, et al. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and meta-analysis［J］. Am J Obstet Gynecol,2011,204(6):501-503.

[17］ Mello G, Parretti E, Fatini C, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women［J］. Hypertension,2005,45(1):86-91.

[18］ Sergio F, Maria CD, Gabriella F, et al. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone［J］. Hypertens Pregnancy,2006,25(2):115-127.

[19］ Facchinetti F, Marozio L, Frusca T, et al. Maternal thrombophilia and the risk of recurrence of preeclampsia［J］. Am J Obstet Gynecol,2009,200(1):41-46.

[20］ de Vries JI, van Pampus MG, Hague WM, et al. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT［J］. J Thromb Haemost,2012,10(1):64-72.

[21］ Kupferminc M, Rimon E, Many A, et al. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia［J］. Blood Coagul Fibrinolysis,2011,22(2):123-126.

[1]	郎景和. 关于妇科复发性疾病与疑难性疾病的若干问题[J]. 中国实用妇科与产科杂志, 2022, 38(5): 481-483.
[2]	张师前. 聚焦关键少数，做好塔尖工作[J]. 中国实用妇科与产科杂志, 2022, 38(5): 484-486.
[3]	王辰, 王颖梅, 薛凤霞. 复发性外阴阴道假丝酵母菌病的预防与治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 487-491.
[4]	彭超, 周应芳. 复发性卵巢子宫内膜异位症的管理[J]. 中国实用妇科与产科杂志, 2022, 38(5): 491-495.
[5]	鲁永鲜. 盆腔器官脱垂手术复发的预防与治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 495-499.
[6]	谢鹏, 郭秋芬, 张师前. 复发性子宫颈癌的综合治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 499-503.
[7]	李一帆, 李宁, 吴令英. 铂耐药复发卵巢上皮性癌的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 503-507.
[8]	徐兴远, 王丹波. 复发性子宫内膜癌的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 507-511.
[9]	生殖健康及重大出生缺陷防控研究高龄产妇妊娠期并发症防治策略研究项目组. 子痫前期防治的集束化管理建议[J]. 中国实用妇科与产科杂志, 2022, 38(5): 534-537.
[10]	万书婷, 王谢桐, . 子宫动脉血流监测在产科的应用[J]. 中国实用妇科与产科杂志, 2022, 38(4): 403-406.
[11]	王一男, 李笑天. 子痫前期临床表现异质性与发病机制的关联性[J]. 中国实用妇科与产科杂志, 2022, 38(2): 138-141.
[12]	赫英东, 陈倩. 子痫前期并发症之外的HELLP综合征[J]. 中国实用妇科与产科杂志, 2022, 38(2): 145-149.
[13]	杨孜. 识子痫前期综合征病因关联再分类提升精准医疗之高度[J]. 中国实用妇科与产科杂志, 2022, 38(1): 13-17.
[14]	陈雨莲，史庭燕，臧荣余. 铂敏感复发卵巢癌手术相关问题与规范化诊疗[J]. 中国实用妇科与产科杂志, 2021, 37(6): 616-620.
[15]	杨孜. 子痫前期综合征分类分层分级管理——制胜临床实践之方向[J]. 中国实用妇科与产科杂志, 2021, 37(5): 505-511.